126 related articles for article (PubMed ID: 8258715)
21. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG
Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847
[TBL] [Abstract][Full Text] [Related]
22. Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysis.
Levy PC; Looney RJ; Shen L; Graziano RF; Fanger MW; Roberts NJ; Ryan DH; Utell MJ
J Immunol; 1990 May; 144(10):3693-700. PubMed ID: 2332629
[TBL] [Abstract][Full Text] [Related]
23. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
Ault KA; Springer TA
J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
Ward RH; Lachmann PJ
Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
[TBL] [Abstract][Full Text] [Related]
25. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS
Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539
[TBL] [Abstract][Full Text] [Related]
26. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.
Sasaki H; Xu XC; Mohanakumar T
J Immunol; 1999 Dec; 163(11):6301-5. PubMed ID: 10570324
[TBL] [Abstract][Full Text] [Related]
27. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of natural killer activity by an antibody to CD44.
Tan PH; Santos EB; Rossbach HC; Sandmaier BM
J Immunol; 1993 Feb; 150(3):812-20. PubMed ID: 8423341
[TBL] [Abstract][Full Text] [Related]
29. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
30. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
Sharland A; Lee JH; Saidman S; Waneck GL
Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
[TBL] [Abstract][Full Text] [Related]
31. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
Komatsu F; Tamiya H
Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
[TBL] [Abstract][Full Text] [Related]
32. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
33. The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.
Kornacker M; Verneris M; Kornacker B; Ganten T; Scheffold C; Negrin R
Cytotherapy; 2006; 8(1):13-23. PubMed ID: 16627341
[TBL] [Abstract][Full Text] [Related]
34. Two distinct mechanisms of cytotoxicity by porcine alveolar macrophages in antibody-dependent and immobilized immune complex-dependent cellular cytotoxicity.
Rothlein R; Kim YB
J Immunol; 1983 Sep; 131(3):1438-42. PubMed ID: 6687337
[TBL] [Abstract][Full Text] [Related]
35. The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectors.
Ramos OF; Kai C; Yefenof E; Klein E
J Immunol; 1988 Feb; 140(4):1239-43. PubMed ID: 2963864
[TBL] [Abstract][Full Text] [Related]
36. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
37. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
38. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
39. A killer cell protective antigen expressed by MHC-unrestricted killer hybridomas.
Kubota K
Cell Immunol; 1997 Oct; 181(1):50-8. PubMed ID: 9344496
[TBL] [Abstract][Full Text] [Related]
40. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
